Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jipan Xie

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Journal of Medical Economics|May 16, 2014
Author responseJipan Xie
Social Science & Medicine (1982)|May 19, 2005
Longitudinal study of child immunization determinants in ChinaJipan Xie, William H Dow
Advances in Therapy|December 16, 2019
Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147-2160. doi:10.1007/s12325-019-00991-wJinlin Song, Wei Gao, Jipan Xie, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 5, 2004
Error identification, disclosure, and reporting: practice patterns of three emergency medicine provider typesCherri Hobgood, Jipan Xie, Bryan Weiner, et al.
The American Journal of Cardiology|April 18, 2007
Electrocardiographic recording and timeliness of clinician evaluation in the emergency department in patients presenting with chest painDavid W Brown, Jipan Xie, George A Mensah
Pharmacoeconomics|February 21, 2014
The role of health economics and outcomes research in health care reform in ChinaWannian Liang, Jipan Xie, Hongpeng Fu, et al.
Journal of Surgical Orthopaedic Advances|March 31, 2009
Seasonal birth patterns of cerebral palsy in North CarolinaJames F Mooney, Lawrence P Lai, Jipan Xie, et al.
Journal of Medical Economics|November 27, 2012
Re.: Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United StatesJipan Xie, Melissa Diener, Rachael Sorg, et al.
Clinical Breast Cancer|June 15, 2012
Cost-effectiveness of denosumab compared with zoledronic acid in patients with breast cancer and bone metastasesJipan Xie, Melissa Diener, Rachael Sorg, et al.
BMJ Open|July 29, 2022
Advancing the development of real-world data for healthcare research in China: challenges and opportunitiesJia Zhong, Jun Zhang, Honghao Fang, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Journal of Medical Economics|May 16, 2014
Author responseJipan Xie
Social Science & Medicine (1982)|May 19, 2005
Longitudinal study of child immunization determinants in ChinaJipan Xie, William H Dow
Advances in Therapy|December 16, 2019
Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147-2160. doi:10.1007/s12325-019-00991-wJinlin Song, Wei Gao, Jipan Xie, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|February 5, 2004
Error identification, disclosure, and reporting: practice patterns of three emergency medicine provider typesCherri Hobgood, Jipan Xie, Bryan Weiner, et al.
The American Journal of Cardiology|April 18, 2007
Electrocardiographic recording and timeliness of clinician evaluation in the emergency department in patients presenting with chest painDavid W Brown, Jipan Xie, George A Mensah
Pharmacoeconomics|February 21, 2014
The role of health economics and outcomes research in health care reform in ChinaWannian Liang, Jipan Xie, Hongpeng Fu, et al.
Journal of Surgical Orthopaedic Advances|March 31, 2009
Seasonal birth patterns of cerebral palsy in North CarolinaJames F Mooney, Lawrence P Lai, Jipan Xie, et al.
Journal of Medical Economics|November 27, 2012
Re.: Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United StatesJipan Xie, Melissa Diener, Rachael Sorg, et al.
Clinical Breast Cancer|June 15, 2012
Cost-effectiveness of denosumab compared with zoledronic acid in patients with breast cancer and bone metastasesJipan Xie, Melissa Diener, Rachael Sorg, et al.
BMJ Open|July 29, 2022
Advancing the development of real-world data for healthcare research in China: challenges and opportunitiesJia Zhong, Jun Zhang, Honghao Fang, et al.
Pageof 11